1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL DISTRIBUTORS
  4. WELLGISTICS HEALTH INC.
Wellgistics Health Inc. XNAS: WGRX
1.34 -0.21 (-13.55%)
2.3M
XNAS Volume

XNAS 28 Aug, 2025 4:06 PM (EDT)

Board Meeting
The next board meeting for Wellgistics Health Inc. is on 03 Sep 2025 for the purpose of Wellgistics Health Inc Annual General Meeting for 2025 See details


Insider Trading disclosures for Wellgistics Health Inc.

The latest disclosure was made by Michael L. Peterson in Wellgistics Health Inc. where a trade of 200,000 Common Stock done at an average price of $0.9 was reported to US exchanges on July 2, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michael L. Peterson Director Grant, award, or other acquisition of securities at price $ 0.90 per share. 02 Jul 2025 200,000 200,000 - 0.9 180,000 Common Stock
Rebecca Shanahan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 200,000 244,720 - 0 Common Stock, Par Value $0.0001
Surendra K. Ajjarapu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 600,000 3,100,000 - 0 Common Stock, Par Value $0.0001
Surendra K. Ajjarapu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 600,000 4,463,200 - 0 Common Stock, Par Value $0.0001
Surendra K. Ajjarapu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 2,882,247 1,822,247 - 0 Common Stock, Par Value $0.0001
Nikul Panchal Chief Pharmacy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 90,000 90,000 - 0 Common Stock, Par Value $0.0001
Shafaat Pirani Chief Clinical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 35,000 102,080 - 0 Common Stock, Par Value $0.0001
Brian Norton Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 9,000,000 9,044,720 - 0 Common Stock, Par Value $0.0001
Sajid Syed Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 200,000 244,720 - 0 Common Stock, Par Value $0.0001
Donald W. Anderson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2025 200,000 244,720 - 0 Common Stock, Par Value $0.0001
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures